Hurst RE - Search Results

1

Molecular and cellular biological approaches and techniques in the detection of bladder cancer and enhanced risk for bladder cancer in high-risk groups.

Hurst RE, Jones PL, Rao JY, Hemstreet GP 3rd. Hurst RE, et al. J Occup Med. 1990 Sep;32(9):854-62. doi: 10.1097/00043764-199009000-00018. J Occup Med. 1990. PMID: 2074508 Review.

2

Identification of a high risk subgroup of grade 1 transitional cell carcinoma using image analysis based deoxyribonucleic acid ploidy analysis of tumor tissue.

Hemstreet GP 3rd, Rollins S, Jones P, Rao JY, Hurst RE, Bonner RB, Hewett T, Smith BG. Hemstreet GP 3rd, et al. Among authors: hurst re. J Urol. 1991 Dec;146(6):1525-9. doi: 10.1016/s0022-5347(17)38157-0. J Urol. 1991. PMID: 1942333

3

Cellular F-actin levels as a marker for cellular transformation: correlation with bladder cancer risk.

Rao JY, Hemstreet GP 3rd, Hurst RE, Bonner RB, Min KW, Jones PL. Rao JY, et al. Among authors: hurst re. Cancer Res. 1991 Jun 1;51(11):2762-7. Cancer Res. 1991. PMID: 2032215

4

Quantitative fluorescence image analysis in bladder cancer screening.

Hemstreet GP 3rd, Hurst RE, Bass RA, Rao JY. Hemstreet GP 3rd, et al. Among authors: hurst re. J Occup Med. 1990 Sep;32(9):822-8. doi: 10.1097/00043764-199009000-00013. J Occup Med. 1990. PMID: 2074505 Review.

5

DNA cytometry and cytology by quantitative fluorescence image analysis in symptomatic bladder cancer patients.

Bass RA, Hemstreet GP 3rd, Honker NA, Hurst RE, Doggett RS. Bass RA, et al. Among authors: hurst re. Int J Cancer. 1987 Nov 15;40(5):698-705. doi: 10.1002/ijc.2910400522. Int J Cancer. 1987. PMID: 3679595

6

Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis.

Rao JY, Hemstreet GP 3rd, Hurst RE, Bonner RB, Jones PL, Min KW, Fradet Y. Rao JY, et al. Among authors: hurst re. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8287-91. doi: 10.1073/pnas.90.17.8287. Proc Natl Acad Sci U S A. 1993. PMID: 8367495 Free PMC article.

7

Bladder cancer risk assessment with quantitative fluorescence image analysis of tumor markers in exfoliated bladder cells.

Bonner RB, Hemstreet GP 3rd, Fradet Y, Rao JY, Min KW, Hurst RE. Bonner RB, et al. Among authors: hurst re. Cancer. 1993 Oct 15;72(8):2461-9. doi: 10.1002/1097-0142(19931015)72:8<2461::aid-cncr2820720826>3.0.co;2-c. Cancer. 1993. PMID: 8402463

8

Characterization of the DD23 tumor-associated antigen for bladder cancer detection and recurrence monitoring. Marker Network for Bladder Cancer.

Bonner RB, Liebert M, Hurst RE, Grossman HB, Bane BL, Hemstreet GP 3rd. Bonner RB, et al. Among authors: hurst re. Cancer Epidemiol Biomarkers Prev. 1996 Dec;5(12):971-8. Cancer Epidemiol Biomarkers Prev. 1996. PMID: 8959319

9

G-actin as a risk factor and modulatable endpoint for cancer chemoprevention trials.

Hemstreet GP 3rd, Rao J, Hurst RE, Bonner RB, Waliszewski P, Grossman HB, Liebert M, Bane BL. Hemstreet GP 3rd, et al. Among authors: hurst re. J Cell Biochem Suppl. 1996;25:197-204. J Cell Biochem Suppl. 1996. PMID: 9027619 Review.

10

Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine.

Hemstreet GP 3rd, Yin S, Ma Z, Bonner RB, Bi W, Rao JY, Zang M, Zheng Q, Bane B, Asal N, Li G, Feng P, Hurst RE, Wang W. Hemstreet GP 3rd, et al. Among authors: hurst re. J Natl Cancer Inst. 2001 Mar 21;93(6):427-36. doi: 10.1093/jnci/93.6.427. J Natl Cancer Inst. 2001. PMID: 11259468

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters